Temozolomide—the jack of all gliomas? Reviewing the interim results of the CATNON trial for 1p/19q non-co-deleted anaplastic glioma

Gliomas are the most common primary neoplasm of the brain parenchyma with a prevalence of 6.0 per 100,000 (1) and are categorized by the glial cells from which they are thought to be derived, including astrocytes, ependymal cells, and oligodendrocytes.